IDENTIFICATION OF INHIBITORS OF DENGUE VIRUS (DENV1, DENV2 AND DENV3) NS2B/ NS3 SERINE PROTEASE: A MOLICULAR DOCKING AND SIMULATION APPROACH by Verma, Renukesh et al.
Vol 8, Issue 1, 2015 ISSN - 0974-2441
IDENTIFICATION OF INHIBITORS OF DENGUE VIRUS (DENV1, DENV2 AND DENV3) NS2B/
NS3 SERINE PROTEASE: A MOLICULAR DOCKING AND SIMULATION APPROACH
RENUKESH VERMA, VINOD K JATAV, SUNITA SHARMA*
Department of Biotechnology, Madhav Institute of Technology and Science, Gwalior – 474005, Madhya Pradesh, India. 
Email: sunitasharma75@yahoo.co.in
Dengue is one of the fatal diseases, which are becoming a global health burden from few decades. Dengue fever, dengue hemorrhagic fever and 
dengue shock syndrome, caused by dengue virus (DENV), which completes its life cycle in mosquito i.e. Aedes aegyti, and human (DENV), and infect 
about various individuals every year. The objective of this study is to find a potent inhibitor of DENV (DENV1, DENV2 and DENV3). In the present 
study, NS2b/NS3 serine protease complex in targeted for the screening of the suitable inhibitors for DENV (DENV1, DENV2 and DENV 3). Therefore, 
the NS2b/NS3 serine protease complex structures were retrieved from the RCSB Protein Databank. The unliganded protein structures were docked, 
and best three selected and analyzed. A molecular dynamic simulation is also performed to investigate the conformational and positional changes 
of ligand that provide insights into the binding stability. It was observed that three of screened compounds have the maximum potential against the 
protein. The analysis was performed on the basis of scoring and binding ability and one of them indicated minimum energy score with high number 
of interactions with active site residues and the simulation study revealed that this selected ligand could efficiently bind to the NS2b/NS3 protease. 
These findings conclude that this selected ligand could be a promising inhibitor of all three serotypes of DENV as drug targets.
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INTRODUCTION
The dengue virus (DENV) belongs to the family Flaviviridae and is 
closely related to the West Nile virus, the yellow fever virus and the 
hepatitis C virus [1]. DENV is ssRNA positive-strand virus consists of 
11,000 bases in its genome that code for three structural proteins; 
coat protein C, membrane protein prM and envelope protein E, seven 
nonstructural proteins; NS 1, NS 2a, NS 2b, NS 3, NS 4a, NS 4b, NS 5 
and short non-coding regions on both the 5’ and 3’ end [1,2]. The U.S. 
Center for Disease Control and Prevention (CDC) estimated that over 
2.5 billion peoples at threat for epidemic transmission [3-5]. It is 
estimated that 100 million cases of dengue fever (DF) and about half 
a million cases of dengue hemorrhagic fever/dengue shock syndrome 
occur worldwide, which cause 25,000 deaths, annually (WHO, 2002). 
DF is an acute febrile disease, which is characterized by sudden onset 
fever of 3-5 days, intense headache, myglia, anthragic retroornital pain, 
anorexia, gastrointestinal disturbance and rash [6]. Currently, there is 
no specific drug or prevention for this disease [2]. This virus contains 
a Type I cap structure at the 5’-end and codes for single polyprotein 
precursor (3391 amino acid residues for DEN2) which is arranged in 
order NH2-C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5-COOH 
(WHO, 2007). For the maturation of the DENV, an optimal activity of 
the NS3 serine protease is essential, and the optimal catalytic activity 
of NS3 requisite the presence of NS2 [7]. This serine protease binds to 
NS2B cofactor that is required to cleave the polyprotein. That NS2B-
NS3 protease complex is requisite for replication of the virus [8]. 
Thus, it serves as a promising target for antiviral drug development 
against the infection of DENV [9,10], in the present study the ligands 
are screened against the SN2b/NS3 serine protease of DENV (DENV1, 
DENV2 and DENV3) to find a common putative drug candidate against 
the NS2b/NS3 serine protease of DENV1, DENV2, DENV3 for treatment 
or development of drug against DENV.
METHODS
Search for sequence similarity
Sequence similarities of NS2b/NS3 serine protease of DENV are 
calculated by CLUSTAL-W [11].
Retrieval of protein structure
The protein structures of NS2b/NS3 Serine Protease of  DENVs were 
retrieved from RCSB Protein Data Bank (PDB) [12] in Brookhaven’s PDB 
format and protein cleaning (removal of ligand and water molecules) 
was done using Autodock 4.2.1 and UCSF Chimera [13].
Binding site prediction
Binding sites, active sites, surface structural pockets (accessible), 
interior cavities (inaccessible), shape (alpha complex and triangulation), 
area and volume (solvent and molecular accessible surface) of each 
pocket and cavities of proteins were found by using CASTp [14].
Compounds selection and preparation
According to Lipinski rule of five several natural derivative compounds 
were filtered from the Zinc Database [15], and then selected 
compounds were screened against three serotypes using AutoDock 
4.2.1. The legends were retrieved in SDF format from the database 
and then converted to PDB format by using Open Babel GUI [16]. All 
values (molecular weight and XlogP) for selection of ligand for docking 
were taken using Zinc Database [15]. Ligand preparation includes the 
addition of hydrogen atoms, neutralization of the charge groups and 
removal of any miscellaneous structures from the ligand by Autodock 
4.2.1. Prepared and optimized structures of ligand and protein were 
ultimately used for molecular docking.
Molecular docking
Virtual screening of the ligand-protein interaction for their binding 
affinity was carried out using AutoDock 4.2.1 [17] and the results that 
include the understanding of the association that involves H-bonding 
and hydrophobic interactions were analyzed using LIGPLOT1.4.5 [18], 
a program to generate schematic diagrams of protein-ligand 
interactions.
The search for the best ways is to fit ligand molecules into structure, 
using Autodock 4.2.1 resulted in docking files that contained detailed 
records of docking. The obtained log files were read in auto dock tool 
to analyze the results of docking. The similarity of docked structures 
was measured by computing the root mean square deviation (RMSD) 
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between the coordinates of the atoms and creating clusters of the 
conformations based on the RMSD values [19]. The lowest binding 
energy conformation in all clusters was considered as the most 
favorable docking pose [19]. Binding energies that are reported 
represent the sum of the total intermolecular energy, total internal 
energy and tensional free energy minus the energy of the unbound 
system [19]. The top three ligands were selected based on the energy 
score after virtual screening.
Molecular dynamic simulation
On the basis of docking result molecular dynamic simulation of 
NS2b/NS3 serine protease of DENV1, DENV2 and DENV3 protein 
with selected ligand were carried out with software GORMACS 4.5.5 
Using gromos force field [20,21]. The protein-ligand complexes were 
placed in the center of a cubic box of dimension 90 Å × 90 Å × 90 Å 
and solved by SPCE/E water molecule. The GROMACS topology files 
for proteins and ligand were generated by command pdb2gmx (reads 
PDB formats and generate GROMACS topology file.gro) and PRODRG 
server [22] (http://davapc1.bioch.dundee.ac.uk/prodrg) respectively. 
These coordinates were used to build the protein-ligand complex. The 
environment was set to 300 K and 1 bar. 100 Pico second. position 
restraining simulations were carried out to restrict the movement of 
the proteins in the simulation. The cutoff for coulomb interaction and 
Vander Waal interaction were set to 1.0 nm and 1.4 nm, respectively, 
of all proteins and the LINCS algorithm, was used for all bond 
constraints.
Absorption, distribution, metabolism, excretion and toxicity 
(ADMET) prediction
The various properties of the best ligand were predicted by using 
Online ACD/I Lab tool (https://ilab.acdlabs.com/iLab2/), and Ames 
test result predicted by Online Chemical Database (https://ochem.eu/
home/show.do) showing.
RESULTS AND DISCUSSION
Search for sequence similarity
The result of CLUSTAL-W shows 73.82, 67.57 and 65.41 scores between 
3L6P and 3U1I, 3L6P and 2FOM and 3U1I and 2FOM respectively (Fig. 1).
Retrieval of protein structure
Structures of DENV NS2b/NS3 serine protease were downloaded from 
PDB (Table 1).
Binding site prediction
Binding pockets were calculated by CastP server and selected according 
to maximum pocket area and pocket volume (Table 2). These pockets 
contains TRP17, GLU19, ALA21, HIS23, HIS28, ASN29, ILE30, LEU31, 
ILE42, LYS43, SER138, TRP139, ASN140, GLY142, GLU143, GLU144, 
VAL145, GLN160, ASN191, ARG192, GLU193 and VAL197 for 3L6P, 
MET49, LYS73, LYS17, LEU76, TRP83, LEU85, GLU86, GLY87, GLU88, 
TRP89, THR118 and THR120 for 2FOM and LYS73, LYS74, LEU76, 
Table 1: Serotype and PDB ID of serotypes of DENV
Serotype PDB ID Length (aa) Resolution (Å)
DENV1 3L6P 236 2.20
DENV2 2FOM 185 1.50
DENV3 3U1I 191 2.30
PDB: Protein data bank, DENV: Dengue virus
Table 2: Pocket information by CastP




Fig. 1: ClustelW result shows the alignment of 3L6P, 3U1I and 
2FOM
THR77, VAL78, MET84, GLN89, TRP89, THR118, THR119, THR120, 
GLY121, GLU122, ILE123, GLY124, VAL147, ASN152, GLY164, ILE165, 
LA166, GLN167, THR168 and ASN169 for 3U1I.
Compounds selection and preparation
18,000 natural compounds were filtered according to Lipinski rule 
of five and then 500 filtered compounds were selected for docking 
(Table 3).
Molecular docking
Analysis of ligand protein complex by ligplot shows hydrogen bonds 
between ligand ZINC4282211 and protein A) 3L6P, B) 2FOM and 
C) 3U1I at Glu193, Glu143 and Ser138, at Glu88, Leu85, Val146, Asn152 
and val147 and at Trp89, Gln167, Gly124 and Val147 respectively 
(Figs. 2-4 and Table 4).
ADMET prediction
Analysis of ligand protein complex by ligplot shows hydrogen bonds 
between ligand ZINC4282211 and protein A) 3L6P, B) 2FOM and 
C) 3U1I at Glu193, Glu143 and Ser138, at Glu88, Leu85, Val146, Asn152 
and val147 and at Trp89, Gln167, Gly124 and Val147 respectively 
(Figs. 2-4 and Tables 4-6).
Molecular dynamic simulation
This investigation revealed that ligand ZINC4282211 could efficiently 
bind to the NS2b/NS3 protease without changing the conformation 
of the protein [23]. To evaluate the stabilities the RMSD and other 
parameters (Table 7) were calculated with respect to initial structures. 
Fig. 2: Ligand ZINC4282211 in the cavity of protein, (a) 3L6P, 
(b) 2FOM, (c) 3U1I
ba
c
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Fig. 3: Molecular visualization of interaction between 





Molecular dynamic simulation showed the stabilization of the proteins 
after 1ns in system with maximum RMSD values of 9.891, 1.805 and 
5.981 nm for 3L6P, 2FOM and 3U1I respectively (Figs. 5 and 6). The 
stability of system proves the stabilization of protein and credential of 
docking results (Figs. 7-9) [23].
Table 3‑ ZINC ID of ligands downloaded from database
1793 265133 1074260 2046841 2554951
19968 338040 1078624 2124579 2572064
58284 485468 1081065 2133555 2575039
134310 488422 1081233 2169830 2583634
134312 488469 1203477 2384668 2586053
134323 517478 1529564 2387029 2596997
155675 518554 1529643 2522476 3156362
155886 518973 1532857 2539694 3212716
156947 1069091 1550030 2539732 3212719
158666 1070097 1672137 2545105 3590892
241780 1074256 1760052 2545107 3653374
3788703 3897841 4028438 4261922 4831392
3814314 3897842 4028439 4261923 4878658
3830179 3900052 4073375 4268259 4878666
3830524 3956712 4073951 4268262 4878672
3830982 3956715 4082020 4268352 5037495
3830983 3956716 4082270 4268354 5037497
3830984 3956720 4095477 4279275 5037498
3830985 3956731 4095490 4282153 5103281
3831470 3977952 4095529 4282211 5126682
3832269 3978744 4095569 4282228 5157172
3847505 3984172 4095664 4303674 5163030
3869396 3984173 4095713 4304316 5178951
3869397 3985065 4095714 4350160 5222064
3869398 3999102 4095786 4513768 5222071
3869520 3999103 4095787 4513770 5224791
3869521 3999104 4096022 4513773 5227195
3869664 3999187 4096145 4521724 5227213
3869665 3999202 4096188 4521723 5239480
3869795 3999203 4096594 4521728 5239485
3869796 3999214 4096638 4544899 5273762
3869810 3999215 4096704 4544905 5273763
3869811 3999312 4096931 4556538 5273764
3869812 3999605 4097029 4556539 5273765
3869910 3999697 4097443 4556540 5341026
3870078 3999698 4097444 4556541 5341027
3870959 3999699 4097529 4556551 5344125
3873956 3999700 4098646 4556852 5420865
3874928 4010856 4098840 4556941 5438604
3875283 4010857 4099041 4557136 5566519
3875284 4010933 4104676 4557391 5566520
3875375 4010934 4104678 4721317 5700054
3881790 4010947 4104822 4721319 5733445
3882070 4015531 4175578 4721320 5736909
3894278 4025052 4217475 4721322 5752331
3897399 4026310 4217548 4787865 5765081
3897400 4026537 4228250 4820559 5765311
3897446 4027427 4228251 4831390 5781539
3897447 4027791 4228295 4831391 5842327
5923622 8551508 13376214 13544222 15251264
5934041 8586495 13376215 13544387 15251267
5954934 8586497 13413424 13544561 15251270
5954938 8628009 13436049 13545523 15262728
5954941 8738281 13436057 13545525 15657731
5954945 8738375 13440025 13547742 17328339
6069213 8738376 13481491 13547790 18033592
6069529 8782776 13481492 13550855 18045874
6069530 8855117 13481493 13551958 18140538
6090974 8869285 13481561 13816232 18166302
6092865 9008779 13507640 14418234 18179993
6184878 11592522 13507867 14418525 18275505
6184881 11592523 13507879 14422035 19312755
6184893 11592524 13508703 14504473 19312821
6360512 11680913 13508877 14504476 19312824
6444474 12358758 13511397 14504479 19312827
6444476 12358840 13512564 14504482 19312830
6444478 12359966 13514113 14504497 19321826
6474030 12359967 13514886 14504500 19322388
6562443 12362075 13515580 14504503 19322865
6562444 12376523 13516052 14512189 19322868
6567584 12377745 13518145 14512194 19322873
6585262 12377746 13520415 14642425 19323012
Table 3: (Continued)
6623665 12406255 13520419 14642428 19323015
6623668 12406257 13520422 14685852 19323021
6930964 12406261 13520517 14685854 19323116
6930996 12495053 13521786 14859228 19323119
6932857 12496482 13527007 14859229 19323325
6932870 12502386 13527740 14859230 19331307
7974994 12502388 13536667 14920311 19331311
8197355 12503321 13536768 14920313 19331315
8197360 12503323 13537301 15113270 19331319
8198840 12503731 13538582 15169388 19331330
8198843 12503733 13538585 15218611 19331334
8376402 12658357 13540027 15218618 19331412
8376405 12890051 13542583 15218624 19331417
8376408 12953204 13542645 15218630 19331424
8376412 13348180 13543975 15251259 26252414
27645575 31163896 35457020 39373976 67903182
28536442 31163900 35457139 39373977 67903185
30724100 31169052 35457147 39373978 67913713
31156872 32109487 35458536 49176734 67913716
31156876 33689262 35464718 49176735 67913718
31156880 33689266 35464732 49181950 67913836
31160626 33834036 35464735 49181952 67913897
31160630 34165724 35465273 49181955 70665126
31160634 34165725 35465276 49181958 71404540
31160638 34165726 35465279 49181973 71404541
31160915 34522850 35878009 49181976 72319970
31160919 34965022 36367411 49181978
31160923 35455284 36367802 49181981
31160927 35455293 39373975 62001311
(Contd...)
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Table 4: Binding energy and other parameters of the ligands
Serotype Parameters Ligand ID
1069091 4097029 4282211




Ki (µm) 31.67 633.61 39.79
H Bonds 8 6 6
MW (g/mol) 340.284 258.143 338.312
XlogP 0.99 −0.06 0.10




Ki (µm) 724.24 251.09 499.67
H Bonds 5 5 7
MW (g/mol) 340.284 258.143 338.312
XlogP 0.99 −0.06 0.10




Ki (µm) 882.26 152.28 664.24
H Bonds 6 7 6
MW (g/mol) 340.284 258.143 338.312
XlogP 0.99 −0.06 0.10
DENV: Dengue virus
Fig. 5: Root mean square deviation graph by MD simulation, (a) 3L6P, (b) 2FOM and (c) 3U1I
ba
c
Fig. 4: Ligplot showing hydrogen bonds between ligand 
ZINC4282211 and protein, (a) 3L6P, (b) 2FOM, (c) 3U1I
ba
c
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Table 5: ADMET and other parameters of ligands
Parameters Ligand ID
1069091 4097029 4282211
Absorption (passive) 19% 2% 72%
BBB (LogPS) −0.45 −8.2 −3.7
Bio availability (oral) <30% <30% Between 30 and 70
pK
Acid 7.8±0.8 0±0.5 12.5±1.0
Base NA 7.8±0.5 NA
Ames test Neg (76%) Neg (78%) Neg (89%)
Density (g/cm3) 1.679±0.06 1.81±0.1 31.78±0.5 10−24
BBB: Blood-brain barrier, ADMET: Absorption, distribution, metabolism, 
excretion and toxicity
Table 6: Predicted qualitative absorbance of ligands by ACD/I 
lab online tool
Ligand ID Threshold Probability Reliability
1069091 10 mg/ml 0.63 Borderline (0.43)
1 mg/ml 0.9 Borderline (0.57)
0.1 mg/ml 0.99 High (0.83)
0.01 mg/ml 1 High (0.79)
4097029 10 mg/ml 1 Moderate (0.74)
1 mg/ml 1 High (0.82)
0.1 mg/ml 1 Moderate (0.73)
0.01 mg/ml 1 Moderate (0.72)
4282211 10 mg/ml 0.67 Not reliable (0.27)
1 mg/ml 0.82 Borderline (0.33)
0.1 mg/ml 0.98 Moderate (0.73)
0.01 mg/ml 0.99 Moderate (0.65)
Table 7: Parameters by molecular dynamic simulation studies
Parameters 3L6P 2FOM 3U1I
RMSD (nm) 9.891 1.805 5.981








RMSD: Root mean square deviation, RMSF: Root mean square fluctuation
Fig. 6: Root mean square fluctuation graph by MD simulation, (a) 3L6P, (b) 2FOM, (c) 3U1I
ba
c
as common drug candidate or development of drug against DENV1, 
DENV2 & DENV3 for treatment of dengue.
CONCLUSION
In this study 500 ligands obtained from Zinc database were docked 
against NS2b/NS3 serine protease of above three serotypes of DENV, 
whose infection results in DF using Autodock 4.2.1 resulted in three 
ligands ZINC1069091, ZINC4097029, ZINC4282211 (Table 4) 
obtained as best compounds. Simulation was done to investigate the 
conformational and positional changes of ligand that provide insights 
in to the binding stability. This investigation revealed that ligand 
ZINC4282211 could efficiently bind to the NS2b/NS3 protease without 
changing the conformation of the protein. To evaluate the stabilities 
the RMSD and other parameters (Table 7) were calculated with 
respect to initial structures. Molecular dynamic simulation shows the 
stabilization of the proteins after 1 ns in system. The stability of system 
proves the stabilization of protein ligand complex.
The present study concludes that the ZINC4282211was found to be 
most active against above three serotypes of DENV and it could be used 
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Fig. 7: (a) Radius of gyration graph, (b) Superimposition of 
structure (opaque before simulation and cyan after simulation) 
of 3L6P
ba
Fig. 8: (a) Radius of gyration graph, (b) Superimposition of 
structure (opaque before simulation and cyan after simulation) 
of 2FOM
ba
Fig. 9: (a) Radius of gyration graph, (b) Superimposition of 
structure (opaque before simulation and cyan after simulation) 
of 3U1I
ba
